Vietnam Investment Review on MSN4h
Ascletis Announces Positive Topline Results of Phase Ib Studies of ASC47 Monotherapy in Australia and U S FDA Clearance of IND Application for ASC47 in Combination with Semaglutide
ASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and 40 days, respectively, in Phase Ib single ...
Some Vegans Were Harmed in the Watching of This Movie
A film critic who provides “vegan alerts” for animal cruelty goes beyond onscreen violence. Milk and eggs are problematic, ...
Natural alternative to Ozempic made mice eat up to 50% less — without side effects
Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.